JavaScript DisabledOur website uses JavaScript. Please confirm that JavaScript is enabled in your browser.
Updated:Publications
A Joint Regional Cohort Study by Shimadzu, Eisai, Oita University, and Usuki City Medical AssociationDemonstrating the Utility of Blood Biomarkers in Predicting Amyloid Beta Accumulation in the Brain
The mass spectrometer LAMS-50K, which Shimadzu Corporation released in 1988, has been recognized as an IEEE Milestone.
Visit Shimadzu at AAIC 2023 - Alzheimer's Association International Conference
To Develop Japan’s First Blood Biomarker-Based Diagnostic Workflow for DementiaShimadzu, Eisai, Oita University, and Usuki City Medical Association Commence Joint Research
Visit Shimadzu at AAIC 2022 - Alzheimer's Association International Conference
Column:MALDI-MS for Glycan Analysis
The MALDImini-1 Honored with iF DESIGN AWARD 2021
Updated:Publications (Technical article for MALDImini-1)
The MALDImini-1 Bestowed the Honor of the “Best of the Best Award” by Red Dot for Product Design
Statistical Analysis of MALDI Mass Spectra Supporting the Discovery of a Novel Species of Genus Pseudomonas
Does the Plasma Amyloid-β Composite Biomarker Associate with Cognitive Decline in Preclinical Alzheimer's Disease? IP-MS will answer.
Discovery of a Novel Class of Hybrid Lipopeptide Compounds using the HiRID™-MS/MS Technology in Collaboration with the University of Tokyo
